Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Colin W. Castleberry, PhD (he/him/his)

Senior Scientist
Amgen
South San Francisco, California, United States

Colin W. Castleberry, PhD., is a senior scientist in Amgen's quantitative pharmacology group within their PKDM department and has gained 8 years of biopharmaceutical modeling experience in both industry and academia. Colin primarily focuses on MIDD for large molecule and RNA therapeutics programs, and has helped drive strategy and decision making for programs in the oncology, cardiometabolic disease, and rare disease therapeutic areas. Prior to Colin's work at Amgen, Colin worked as a biotechnology researcher with AbbVie as he completed his graduate studies. Colin is a systems biologist by training and was awarded a PhD in Bioengineering from the University of Illinois at Urbana Champaign in 2022. Colin is also a passionate teacher and mentor, and has performed research in the engineering education domain to facilitate adaptive teaching and adaptive assessment in higher education courses.

Disclosure(s): Amgen: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentation(s):

Email Colin